We describe the case of an HIV-1-infected patient presenting with acute obstructive jaundice as the initial manifestation of primary small bowel Burkitt's lymphoma. The biliary obstruction resolved rapidly following chemotherapy without the need for surgical intervention. The prognosis is favourable with appropriate timely treatment.
KesselB, MoisseievE, KorinA, Burkitt's lymphoma: an unusual cause of obstructive jaundice. Asian J Surg2005;28:301–04
4.
UgarH, TacyilidizN, YavuzG, Obstructive jaundice: an unusual initial manifestation of intra-abdominal non-Hodgkin's lymphoma in a child. Pediatr Haematol Oncol2006;23:87–90
5.
SchoeppnerHL, WongDK, BresalierRS. Primary small bowel lymphoma manifested as obstructive jaundice in a patients with AIDS. South Med J1995;5:583–85
6.
WangES, StrausDJ, Teruya-FeldsteinJ, Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer2003;98:1196–205
7.
CortesJ, ThomasD, RiosA, Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer2002;94:1492–9
8.
GalicierL, FieschiC, BorieR, Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood2007;110:2846–54
9.
OriolA, RiberaJM, BerguaJ, High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer2008;113:117–25
10.
BowerM, CollinsS, CottrillC, British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med2008;9:336–88
